Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 91-100 of 125 for kidney and hypertension

Edit search filters
  1. A Study of the Frequency of Kidney Stone Formation in Liver Disease Patients

    Jacksonville, FL

  2. A Study to Evaluate the Role of NOX4 and Related Biomarkers in Autosomal Dominant Polycystic Kidney Disease

    Rochester, MN

  3. The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) 4

    Rochester, MN

  4. Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients

    Rochester, MN

  5. Biobank Protocol, Rare Diseases Clinical Research Network

    Rochester, MN

  6. Predicting Stone Recurrence on CT Scan

    Jacksonville, FL, Rochester, MN

  7. A Study to Learn More About Improving Mesenchymal Stem Cells and Its Application in Chronic Kidney Disease Due to Hypertensive Nephropathy

    Rochester, MN

  8. Rapid Detection of Acute Kidney Injury (AKI) in Hospitalized Patients

    Scottsdale/Phoenix, AZ

  9. Validation Of The NEPHROCLEARTM CCL14 Test In The Intensive Care Unit (ICU) For Risk Assessment Of Persistent Severe Acute Kidney Injury

    Rochester, MN

  10. New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease

    Rochester, MN

.

Mayo Clinic Footer